News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
726,950 Results
Type
Article (44390)
Company Profile (440)
Press Release (682119)
Multimedia
Podcasts (93)
Webinars (16)
Section
Business (210068)
Career Advice (2228)
Deals (36206)
Drug Delivery (107)
Drug Development (84121)
Employer Resources (176)
FDA (16623)
Job Trends (15287)
News (355429)
Policy (33506)
Tag
Academia (2690)
Accelerated approval (12)
Adcomms (29)
Allergies (100)
Alliances (51424)
ALS (115)
Alzheimer's disease (1506)
Antibody-drug conjugate (ADC) (169)
Approvals (16601)
Artificial intelligence (334)
Autoimmune disease (34)
Automation (19)
Bankruptcy (375)
Best Places to Work (11906)
BIOSECURE Act (20)
Biosimilars (126)
Biotechnology (332)
Bladder cancer (98)
Brain cancer (37)
Breast cancer (375)
Cancer (2972)
Cardiovascular disease (229)
Career advice (1859)
Career pathing (30)
CAR-T (194)
CDC (32)
Cell therapy (529)
Cervical cancer (22)
Clinical research (69010)
Collaboration (1070)
Company closure (3)
Compensation (700)
Complete response letters (28)
COVID-19 (2718)
CRISPR (65)
C-suite (344)
Cystic fibrosis (118)
Data (3056)
Decentralized trials (2)
Denatured (31)
Depression (72)
Diabetes (355)
Diagnostics (6520)
Digital health (24)
Diversity (9)
Diversity, equity & inclusion (46)
Drug discovery (147)
Drug pricing (133)
Drug shortages (29)
Duchenne muscular dystrophy (133)
Earnings (89024)
Editorial (46)
Employer branding (21)
Employer resources (151)
Events (117968)
Executive appointments (876)
FDA (18304)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (978)
Gene editing (142)
Generative AI (24)
Gene therapy (408)
GLP-1 (843)
Government (4683)
Grass and pollen (5)
Guidances (181)
Healthcare (19372)
HIV (42)
Huntington's disease (31)
IgA nephropathy (43)
Immunology and inflammation (165)
Immuno-oncology (10)
Indications (40)
Infectious disease (2898)
Inflammatory bowel disease (156)
Inflation Reduction Act (13)
Influenza (65)
Intellectual property (123)
Interviews (357)
IPO (16913)
IRA (47)
Job creations (3800)
Job search strategy (1572)
Kidney cancer (13)
Labor market (52)
Layoffs (530)
Leadership (19)
Legal (8126)
Liver cancer (81)
Longevity (11)
Lung cancer (418)
Lymphoma (212)
Machine learning (11)
Management (59)
Manufacturing (405)
MASH (94)
Medical device (13671)
Medtech (13676)
Mergers & acquisitions (20011)
Metabolic disorders (899)
Multiple sclerosis (99)
NASH (21)
Neurodegenerative disease (129)
Neuropsychiatric disorders (39)
Neuroscience (2226)
NextGen: Class of 2025 (6847)
Non-profit (4629)
Now hiring (47)
Obesity (458)
Opinion (241)
Ovarian cancer (103)
Pain (112)
Pancreatic cancer (122)
Parkinson's disease (193)
Partnered (22)
Patents (306)
Patient recruitment (170)
Peanut (51)
People (59437)
Pharmaceutical (86)
Pharmacy benefit managers (23)
Phase I (21678)
Phase II (30423)
Phase III (22517)
Pipeline (1668)
Policy (214)
Postmarket research (2633)
Preclinical (9310)
Press Release (67)
Prostate cancer (147)
Psychedelics (44)
Radiopharmaceuticals (273)
Rare diseases (491)
Real estate (6120)
Recruiting (68)
Regulatory (23291)
Reports (50)
Research institute (2462)
Resumes & cover letters (385)
Rett syndrome (9)
RNA editing (10)
RSV (51)
Schizophrenia (94)
Series A (169)
Series B (116)
Service/supplier (11)
Sickle cell disease (66)
Special edition (21)
Spinal muscular atrophy (154)
Sponsored (33)
Startups (3808)
State (2)
Stomach cancer (15)
Supply chain (77)
Tariffs (59)
The Weekly (60)
Vaccines (820)
Venture capital (56)
Weight loss (289)
Women's health (49)
Worklife (17)
Date
Today (84)
Last 7 days (367)
Last 30 days (1878)
Last 365 days (32113)
2025 (17333)
2024 (36389)
2023 (41112)
2022 (52403)
2021 (56922)
2020 (55180)
2019 (47818)
2018 (36043)
2017 (33303)
2016 (32699)
2015 (38753)
2014 (32493)
2013 (27415)
2012 (29483)
2011 (30159)
2010 (28267)
Location
Africa (774)
Alabama (67)
Alaska (7)
Arizona (253)
Arkansas (14)
Asia (40064)
Australia (6673)
California (7608)
Canada (2386)
China (699)
Colorado (328)
Connecticut (333)
Delaware (195)
Europe (88247)
Florida (1127)
Georgia (250)
Hawaii (1)
Idaho (60)
Illinois (662)
India (28)
Indiana (365)
Iowa (18)
Japan (232)
Kansas (112)
Kentucky (30)
Louisiana (15)
Maine (64)
Maryland (1048)
Massachusetts (5753)
Michigan (248)
Minnesota (458)
Mississippi (3)
Missouri (91)
Montana (30)
Nebraska (25)
Nevada (81)
New Hampshire (70)
New Jersey (2124)
New Mexico (30)
New York (2123)
North Carolina (1156)
North Dakota (9)
Northern California (3322)
Ohio (239)
Oklahoma (16)
Oregon (38)
Pennsylvania (1632)
Puerto Rico (17)
Rhode Island (38)
South America (1149)
South Carolina (34)
South Dakota (1)
Southern California (2835)
Tennessee (126)
Texas (1149)
United States (28321)
Utah (223)
Virginia (192)
Washington D.C. (74)
Washington State (658)
West Virginia (4)
Wisconsin (70)
726,950 Results for "five prime therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Prime Therapeutics’ leading research shows only 1 in 12 remain on a GLP-1 drug for obesity at three years
June 26, 2025
·
3 min read
Press Releases
InspireMD Announces FDA Approval for CGuard® Prime Carotid Stent System for the Prevention of Stroke
June 25, 2025
·
8 min read
Press Releases
Candid Therapeutics Advances Portfolio of Novel T-Cell Engagers into Five Autoimmune Diseases for Clinical Evaluation
June 20, 2025
·
4 min read
Press Releases
Prime Medicine to Participate in Upcoming June 2025 Investor Conferences
May 30, 2025
·
2 min read
Press Releases
Prime Medicine Announces Breakthrough Clinical Data Showing Rapid Restoration of DHR Positivity After Single Infusion of PM359, an Investigational Prime Editor for Chronic Granulomatous Disease
May 19, 2025
·
10 min read
Press Releases
Prime Therapeutics highlights industry-leading GLP-1 research at AMCP 2025
April 1, 2025
·
4 min read
Press Releases
Stratus Announces Publication of Stratus PRIME™ HSC Platform in the American Journal of Hematology
May 23, 2025
·
2 min read
Press Releases
InspireMD Announces CE Mark Approval for CGuard® Prime Embolic Prevention System (EPS) Under European MDR for the Prevention of Stroke
June 16, 2025
·
5 min read
Press Releases
GRIN Therapeutics Receives Priority Medicines (PRIME) Designation from EMA for Radiprodil in the Treatment of GRIN-Related Neurodevelopmental Disorder
April 1, 2025
·
6 min read
Press Releases
Cytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 2025
July 11, 2025
·
5 min read
1 of 72,695
Next
